Eligibility of emergency psychiatry patients for clinical trials studying depression

被引:0
|
作者
Lawrence, Ryan E. [1 ,2 ]
Bernstein, Adam [3 ]
Jaffe, Chaya [4 ]
Zhao, Yinjun [5 ]
Wang, Yuanjia [6 ]
Goldberg, Terry E. [7 ]
机构
[1] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY 10027 USA
[2] Presbyterian Hosp, New York State Psychiat Inst, Comprehens Psychiat Emergency Program New York, 1051 Riverside Dr, New York, NY 10032 USA
[3] Creedmoor Psychiat Ctr, Queens, NY USA
[4] New York State Psychiat Inst & Hosp, New York, NY USA
[5] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA
[6] Columbia Univ, Dept Biostat, New York, NY USA
[7] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA
关键词
Depression; Clinical trial; Exclusion criteria; Emergency psychiatry; ANTIDEPRESSANT EFFICACY TRIALS; EXCLUSION CRITERIA; SAMPLES; GENERALIZABILITY; INCLUSION; DISORDER; ALCOHOL;
D O I
10.1016/j.jad.2023.09.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Differences often exist between people with depression who are eligible for clinical trials and those seen in clinical practice. The impact of exclusion criteria on eligibility has been previously reported for inpatients and outpatients, but has not been assessed for emergency psychiatry patients; a group that overlaps with inpatients and outpatients but also has important distinctives. Understanding the frequencies of commonly used exclusion criteria in this population could inform interpretation of existing data (generalizability) and highlight opportunities/needs for future trials.Methods: We reviewed 67 clinical trials studying depression using Qualitative Content Analysis to identify common and recurring exclusion criteria. We examined the frequency of these exclusion criteria among a clinical sample of emergency psychiatry patients. Results: Most clinical trials had exclusions for basic research requirements, age, symptom severity, psychosis, and substance use. Applying 9 commonly used exclusion criteria to the clinical population resulted in a 3.3 % eligibility rate (95 % CI 1.2 %-7.0 %). Exclusions for psychosis (85.1 % of trials), substance use (83.6 % of trials), and suicide risk (65.7 % of trials) would likely exclude 93 % of emergency psychiatry patients. The prevalence of psychosis, substance use, and suicide risk was much higher among emergency psychiatry patients than among previously studied populations. Limitations: Some eligibility criteria could not be measured. The Qualitative Content Analysis consolidated similar exclusion criteria, losing potentially important nuances in wordings.Conclusions: Exclusion criteria commonly used in contemporary clinical trials of depression limit generalizability to emergency psychiatry patients, due in large part to exclusions for psychosis, substance use, and suicide risk.
引用
收藏
页码:10 / 15
页数:6
相关论文
共 50 条
  • [41] Diversity in randomized clinical trials of depression: A 36-year review
    Polo, Antonio J.
    Makol, Bridget A.
    Castro, Ashley S.
    Colon-Quintana, Nicole
    Wagstaff, Amanda E.
    Guo, Sisi
    CLINICAL PSYCHOLOGY REVIEW, 2019, 67 : 22 - 35
  • [42] Science in a crisis: conducting clinical trials in an emergency
    P Horby
    Trials, 16 (Suppl 2)
  • [43] Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
    Mercier, Benjamin D.
    Govindarajan, Ameish
    Castro, Daniela V.
    Li, Xiaochen
    Philip, Errol J.
    Feng, Matthew I.
    Prajapati, Sweta R.
    Chan, Elyse H.
    Lee, Kyle O.
    Sehgal, Ishaan
    Patel, Jalen
    O'Dell, Anna
    Chehrazi-Raffle, Alexander
    Ebrahimi, Hedyeh
    Rock, Adam
    Zengin, Zeynep Busra
    Meza, Luis A.
    Dizman, Nazli
    Hsu, Joann
    Liu, Sandy
    Dorff, Tanya B.
    Pal, Sumanta K.
    Tripathi, Abhishek
    CANCER MEDICINE, 2025, 14 (07):
  • [44] Depression and cardiovascular disease: Time for clinical trials
    Catalina-Romero, Carlos
    Calvo-Bonacho, Eva
    ATHEROSCLEROSIS, 2017, 257 : 250 - 252
  • [45] Clinical trials of PUFAs in depression: State of the art
    Osher, Yamima
    Belmaker, Robert H.
    Nemets, Boris
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2006, 7 (04) : 223 - 230
  • [46] Clinical relevance of findings in trials of CBT for depression
    Lepping, P.
    Whittington, R.
    Sambhi, R. S.
    Lane, S.
    Poole, R.
    Leucht, S.
    Cuijpers, P.
    McCabe, R.
    Waheed, W.
    EUROPEAN PSYCHIATRY, 2017, 45 : 207 - 211
  • [47] MRI-based screening for structural definition of eligibility in clinical DMOAD trials: Rapid OsteoArthritis MRI Eligibility Score (ROAMES)
    Roemer, F. W.
    Collins, J.
    Kwoh, C. K.
    Hannon, M. J.
    Neogi, T.
    Felson, D. T.
    Hunter, D. J.
    Lynch, J. A.
    Guermazi, A.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 (01) : 71 - 81
  • [48] Patterns of marijuana use among psychiatry patients with depression and its impact on recovery
    Bahorik, Amber L.
    Leibowitz, Amy
    Sterling, Stacy A.
    Travis, Adam
    Weisner, Constance
    Satre, Derek D.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 213 : 168 - 171
  • [49] SCREENING FOR DEPRESSION IN EMERGENCY DEPARTMENT PATIENTS
    Hoyer, David
    David, Elizabeth
    JOURNAL OF EMERGENCY MEDICINE, 2012, 43 (05) : 786 - 789
  • [50] Mortality during US FDA clinical trials in patients with diabetes, hypertension, depression and schizophrenia
    Khan, Arif
    Mar, Kaysee Fahl
    Gokul, Sagarika
    Brown, Walter A.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2020, 21 (01) : 64 - 71